Winston Total Other Income Expense Net from 2010 to 2026
| WPHM Stock | USD 0.0003 0.00 0.00% |
Total Other Income Expense Net | First Reported 2010-12-31 | Previous Quarter 77.3 K | Current Value 45.8 K | Quarterly Volatility 15.2 K |
Check Winston Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Winston Pharmaceuticals' main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 1.5 M, as well as many indicators such as Price To Sales Ratio of 8.02, Dividend Yield of 0.0 or PTB Ratio of 10.66. Winston financial statements analysis is a perfect complement when working with Winston Pharmaceuticals Valuation or Volatility modules.
Winston | Total Other Income Expense Net | Build AI portfolio with Winston Stock |
Latest Winston Pharmaceuticals' Total Other Income Expense Net Growth Pattern
Below is the plot of the Total Other Income Expense Net of Winston Pharmaceuticals over the last few years. It is Winston Pharmaceuticals' Total Other Income Expense Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Winston Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Total Other Income Expense Net | 10 Years Trend |
|
Total Other Income Expense Net |
| Timeline |
Winston Total Other Income Expense Net Regression Statistics
| Arithmetic Mean | 80,048 | |
| Geometric Mean | 78,033 | |
| Coefficient Of Variation | 19.00 | |
| Mean Deviation | 9,664 | |
| Median | 85,916 | |
| Standard Deviation | 15,213 | |
| Sample Variance | 231.4M | |
| Range | 51K | |
| R-Value | 0.02 | |
| Mean Square Error | 246.7M | |
| R-Squared | 0.0005 | |
| Significance | 0.93 | |
| Slope | 66.73 | |
| Total Sum of Squares | 3.7B |
Winston Total Other Income Expense Net History
About Winston Pharmaceuticals Financial Statements
Winston Pharmaceuticals investors utilize fundamental indicators, such as Total Other Income Expense Net, to predict how Winston Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Other Income Expense Net | 77.3 K | 45.8 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Winston Pharmaceuticals Correlation against competitors. To learn how to invest in Winston Stock, please use our How to Invest in Winston Pharmaceuticals guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Drug Manufacturers - Specialty & Generic space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Winston Pharmaceuticals. If investors know Winston will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Winston Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Winston Pharmaceuticals is measured differently than its book value, which is the value of Winston that is recorded on the company's balance sheet. Investors also form their own opinion of Winston Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Winston Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Winston Pharmaceuticals' market value can be influenced by many factors that don't directly affect Winston Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Winston Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Winston Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Winston Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.